NeoGenomics, Inc. Inventory
NeoGenomics, Inc. (NEO) had Inventory of $27.14 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-28
- 2026-06-30: Inventory, Net $27.14M.
- 2026-03-31: Inventory, Net $29.84M.
- 2025-12-31: Inventory, Net $28.57M.
- 2025-09-30: Inventory, Net $28.46M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $27.14M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $29.84M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $28.57M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $28.46M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $34.17M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $29.77M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $26.75M 10-K · filed 2026-02-17 |
| 2024-09-30 | $24.46M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $23.21M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $20.32M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $24.16M 10-K · filed 2025-02-18 |
| 2023-09-30 | $24.05M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $24.95M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $24.43M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $24.28M 10-K · filed 2024-02-20 |
| 2022-09-30 | $23.80M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $21.86M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $23.84M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $23.39M 10-K · filed 2023-02-24 |
| 2021-09-30 | $21.83M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $21.38M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $21.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $29.53M 10-K · filed 2022-02-25 |
| 2020-09-30 | $20.64M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $21.63M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $20.29M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $14.40M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.63M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $8.73M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $9.67M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $8.65M 10-K · filed 2020-02-28 |
| 2018-09-30 | $6.83M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $6.90M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $7.51M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $7.47M 10-K · filed 2019-02-26 |
| 2017-09-30 | $6.09M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $5.46M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $5.97M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $6.25M 10-K · filed 2018-03-13 |
| 2016-09-30 | $5.95M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $5.54M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $5.33M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $5.11M 10-K · filed 2017-03-14 |
| 2015-09-30 | $2.97M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $3.42M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $2.60M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.62M 10-K · filed 2016-04-18 |
| 2014-09-30 | $2.97M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $2.62M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $2.00M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.30M 10-K · filed 2015-03-03 |
| 2013-09-30 | $2.07M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $1.74M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $1.65M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $1.86M 10-K · filed 2014-02-24 |
| 2012-09-30 | $1.91M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.53M 10-Q/A · filed 2012-08-15 |
| 2012-03-31 | $1.31M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $1.20M 10-K · filed 2013-02-21 |
| 2011-09-30 | $1.10M 10-Q · filed 2011-10-25 |
| 2011-06-30 | $1.08M 10-Q/A · filed 2011-08-01 |
| 2010-12-31 | $887.00K 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |